Canberra — Cancer continues as one of Australia's leading causes of death, claiming an estimated 53,545 lives in 2025 according to projections from Cancer Australia and the Australian Institute of Health and Welfare (AIHW). While overall age-standardised mortality rates have declined steadily—from 257 deaths per 100,000 people in 2000 to an estimated 194 in 2025—specific cancers still dominate fatal outcomes. Lung cancer persists as the top killer in most recent data, though a 2025 analysis shows upper gastrointestinal (GI) cancers narrowly surpassing it in 2024 figures, highlighting shifting patterns driven by prevention successes and persistent risks.

Lung Cancer Remains Australia's Deadliest Despite Upper GI Cancers' Rise
Lung Cancer Remains Australia's Deadliest Despite Upper GI Cancers' Rise in 2025-2026 Mortality Data

The latest available national statistics, drawn from AIHW's October 2025 "Cancer Data in Australia" report and Cancer Australia's 2025 estimates, combined with Australian Bureau of Statistics (ABS) cause-of-death releases through late 2025, reveal the five cancers responsible for the most deaths. These rankings reflect both historical trends and emerging challenges, including low survival rates for aggressive types and the impact of modifiable risk factors like smoking, alcohol, obesity, and infections.

  1. Lung Cancer — Lung cancer has long held the grim distinction as Australia's leading cause of cancer death, and it remains so in 2025 projections. Cancer Australia estimates 8,994 deaths in 2025 (5,001 males, 3,993 females), with an age-standardised mortality rate of 33 per 100,000 people. In 2023, the figure stood at 8,976 deaths. Despite declining smoking rates contributing to gradual reductions, lung cancer accounts for roughly 17% of cancer fatalities due to late diagnosis and poor five-year survival—around 27% in recent periods, up from under 10% decades ago but still the lowest among major cancers. Tobacco remains the primary risk, though radon, asbestos, and air pollution play roles.
  2. Colorectal (Bowel) Cancer — Bowel cancer ranks second in cancer deaths, with consistent high burden. ABS provisional data for 2024 showed around 5,387 deaths from malignant neoplasms of the colon, sigmoid, rectum, and anus, and similar patterns hold for 2025 estimates. The cancer's relatively high incidence—second or third most diagnosed—combines with five-year survival of about 72% to produce substantial mortality. Screening programs have improved early detection, but late-stage diagnoses in younger adults contribute to ongoing deaths. Risk factors include diet, obesity, alcohol, and family history.
  3. Pancreatic Cancer (part of Upper GI Group) — Pancreatic cancer stands out for its lethality, with five-year survival often below 10%. While exact 2025 standalone figures vary, it forms a major component of upper GI cancers, which collectively overtook lung cancer as the top cause in 2024 per Pancare Foundation analysis of ABS data—9,301 upper GI deaths versus 9,119 for lung. Pancreatic cases drive much of this group's mortality due to vague symptoms like weight loss and fatigue delaying diagnosis. Projections suggest continued high impact in 2025-2026.
  4. Prostate Cancer — Prostate cancer causes significant male deaths despite high incidence and better survival in many cases. Mortality has declined markedly, from peak rates of 63 per 100,000 males in the 1990s to an estimated 33 in 2025. Still, it ranks among the top five due to volume, with thousands of deaths annually. Early detection via PSA testing and advances in treatment have improved outcomes, but aggressive forms remain deadly.
  5. Breast Cancer — Breast cancer leads female cancer deaths in some metrics and ranks high overall. Mortality rates have fallen from around 38 per 100,000 females in the late 1980s to about 22 in 2025 estimates. Mammography screening and targeted therapies contribute to better survival, yet it claims thousands of lives yearly, often in advanced or metastatic cases.

Overall trends offer encouragement: age-standardised cancer mortality has dropped significantly over decades, thanks to reduced smoking, better screening, and treatments. Yet absolute deaths rise with population ageing and growth, reaching over 53,000 projected for 2025. Cancer Australia notes a 1 in 7 lifetime risk of dying from cancer by age 85.

Prevention remains key. Up to 38% of cases and deaths tie to modifiable factors, per Queensland Chief Health Officer data. Public health efforts target smoking cessation, alcohol reduction, HPV vaccination (reducing cervical but relevant broadly), and healthy lifestyles.

Rising early-onset cancers in under-50s—colorectal, pancreatic, liver, and others—alarm experts, with increases of 100-500% in some types since 2000. Research into diet, environment, and microbiome factors intensifies.

As Australia navigates these challenges, organisations like Cancer Council and Pancare advocate for awareness, research funding, and equitable access to care. While progress slows mortality rates, lung, bowel, pancreatic, prostate, and breast cancers underscore the need for continued vigilance and innovation in prevention, detection, and treatment.